Precision Medicine Strategies for Medulloblastoma Therapy
Objectives and Disclosures
- Analyze the basis of medulloblastoma molecular classification
- Evaluate how this new classification has changed our understanding of the disease as well as changed our approach to therapy
- Assess new strategies to develop targeted therapies based on the molecular profiles of the tumors
Planners and speaker disclose they have no relevant financial relationships.
Sarkowsky Neurology Lecture
Scott Pomeroy, MD, PhD
Seattle Children’s is accredited by the Washington State Medical Association CME Accreditation Committee to sponsor continuing medical education for physicians.
Seattle Children’s designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 1 hour of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Videos are available for only one year after posting.
If you wish to receive Category I CME credit for viewing this Provider Grand Rounds session, please complete the evaluation form. Upon completion of the form you will receive an auto-reply email that will serve as the only confirmation of your CME credit. Please keep the email for your records.